De Bock Alexander reported grant involving 836,036 derivative units of Lucid Group, Inc. at $0.00 for $0 on Nov 5, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Financial Officer
Chief Financial Officer
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
836,036Peformance Restricted Stock Unit
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
836,036Direct
Trade date
Nov 5, 2026Grant
Filed
Nov 9, 2026, 5:02 PM ET4-day reporting delay
Accession
0001628280-26-072314Code A · Transaction 396200
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

LCID price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
LCID · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +16%1w ago −11%1d ago −6.4%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents performance-based restricted stock units that are divided into four tranches and subject to both time-based and performance-based vesting conditions. A given tranche vests upon the later of (x) the tranche's time-based vesting date (which is no sooner than November 5, 2028, for tranches 1 and 2, and no sooner than November 5, 2029, for tranches 3 and 4) and (y) certification of achievement of the market capitalization performance hurdle applicable to each tranche ($3.5 billion, $5.0 billion, $6.5 billion and $8.0 billion for tranches 1, 2, 3, and 4 respectively, calculated in accordance with the reporting person's performance stock unit agreement), in each case, subject to the reporting person's continued employment with the Issuer or its subsidiary through each vesting date.